A seasoned executive with broad experience including his tenure He obtained his medical degree from Tongji Medical College, a PhD from Cornell University, and worked as a research associate at Memorial Sloan-Kettering Cancer Center.

30 years of sales and marketing management experience within the diagnostic market, the last fifteen years focused exclusively within early stage companies. Graeme was most recently employed as Director of Global Marketing for Invivoscribe and previously held senior positions with Ipsogen, Cytocell and Speywood Pharmaceuticals. Graeme began his commercial career at Ortho Diagnostic Systems, UK and was previously an MLSO with the UK’s NHS.

Prior to establish QuanDx Inc., Dr. Yu is the president, CEO and Chairman of the Board of Epitomics, acquired by Abcam in 2012. Dr.Yu has more than 12 years of experience in genomics and 24 years of experience in life sciences research.